Efficacy and safety of brexpiprazole for the treatment of acute schizophrenia in Japan: A 6-week, randomized, double-blind, placebo-controlled study - Ishigooka, J; Iwashita, S; Tadori, Y (Psychiatry Clin Neurosci, 2018)